Explore our tests
Discover the right genetic test for your patient in our complete list of tests and panels.
Showing 10 out of 406 tests
Multiple Endocrine Neoplasia Type 1 via the MEN1 Gene
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7503
2 - 3 weeks (7 - 16 days STAT)•Test 75031 Gene
Multiple Endocrine Neoplasia Type 2A (MEN2A), Type 2B (MEN2B), and Familial Medullary Thyroid Carcinoma (FMTC) via the RET Gene
NGS with CNV (PGselect Platform)2 - 3 weeks (7 - 16 days STAT)•Test 4673
2 - 3 weeks (7 - 16 days STAT)•Test 46731 Gene
Multiple Epiphyseal Dysplasia Panel
NGS with CNV (Exome or Genome Platform)2 - 3 weeks (6 - 12 days STAT)•Test 10247
2 - 3 weeks (6 - 12 days STAT)•Test 1024710 Genes
My Retina Tracker Program
Sponsored TestNGS with CNV (PGselect Platform)2 - 3 weeks•Test 16023
2 - 3 weeks•Test 16023110 Genes
NavigATTR Sponsored Testing Program
Sponsored TestNGS with CNV (PGselect Platform)2 - 3 weeks•Test 15139
2 - 3 weeks•Test 151391 Gene
Nemaline Myopathy (NEM2) via the Nebulin (NEB) Gene
NGS with CNV (Exome or Genome Platform)2 - 3 weeks (7 - 16 days STAT)•Test 1772
2 - 3 weeks (7 - 16 days STAT)•Test 17721 Gene
Nemaline Myopathy via the NEB Exon 55 Deletion
Targeted PCR2 - 3 weeks (8 - 10 days STAT)•Test 356
2 - 3 weeks (8 - 10 days STAT)•Test 3561 Gene
Nemaline Myopathy via the NEB Gene, Exons 82-105 (Triplicate Repeat Region)
Sanger Sequencing3 - 4 weeks (12 - 19 days STAT)•Test 2079
3 - 4 weeks (12 - 19 days STAT)•Test 20791 Gene
Neonatal Respiratory Distress Panel
NGS with CNV (Exome or Genome Platform)2 - 3 weeks (6 - 12 days STAT)•Test 13349
2 - 3 weeks (6 - 12 days STAT)•Test 133495 Genes
Nephrolithiasis and Nephrocalcinosis Panel
NGS with CNV (Exome or Genome Platform)2 - 3 weeks (6 - 12 days STAT)•Test 10395
2 - 3 weeks (6 - 12 days STAT)•Test 1039530 Genes